title: Derivation of neural stem cells from an animal model of psychiatric disease.
abstract: Several psychiatric and neurological diseases are associated with altered hippocampal neurogenesis, suggesting differing neural stem cell (NSC) function may play a critical role in these diseases. To investigate the role of resident NSCs in a murine model of psychiatric disease, we sought to isolate and characterize NSCs from alpha-calcium-/calmodulin-dependent protein kinase II heterozygous knockout (CaMK2α-hKO) mice, a model of schizophrenia/bipolar disorder. These mice display altered neurogenesis, impaired neuronal development and are part of a larger family possessing phenotypic and behavioral correlates of schizophrenia/bipolar disorder and a shared pathology referred to as the immature dentate gyrus (iDG). The extent to which NSCs contribute to iDG pathophysiology remains unclear. To address this, we established heterogeneous cultures of NSCs isolated from the hippocampal neuropoietic niche. When induced to differentiate, CaMK2α-hKO-derived NSCs recapitulate organotypic hippocampal neurogenesis, but generate larger numbers of immature neurons than wild-type (WT) littermates. Furthermore, mutant neurons fail to assume mature phenotypes (including morphology and MAP2/calbindin expression) at the same rate observed in WT counterparts. The increased production of immature neurons which fail to mature indicates that this reductionist model retains key animal- and iDG-specific maturational deficits observed in animal models and human patients. This is doubly significant, as these stem cells lack several developmental inputs present in vivo. Interestingly, NSCs were isolated from animals prior to the emergence of overt iDG pathophysiology, suggesting mutant NSCs may possess lasting intrinsic alterations and that altered NSC function may contribute to iDG pathophysiology in adult animals.
authors.affiliation: 1] Free University Medical Center, Amsterdam, HZ, The Netherlands [2] CNS, Astellas Research Institute of America LLC, Skokie, IL, USA.
authors.forename: A
authors.initials: A
authors.lastname: de Koning
authors.forename: N M
authors.initials: NM
authors.lastname: Walton
authors.forename: R
authors.initials: R
authors.lastname: Shin
authors.forename: Q
authors.initials: Q
authors.lastname: Chen
authors.forename: S
authors.initials: S
authors.lastname: Miyake
authors.forename: K
authors.initials: K
authors.lastname: Tajinda
authors.forename: A K
authors.initials: AK
authors.lastname: Gross
authors.forename: J H
authors.initials: JH
authors.lastname: Kogan
authors.forename: C L
authors.initials: CL
authors.lastname: Heusner
authors.forename: K
authors.initials: K
authors.lastname: Tamura
authors.forename: M
authors.initials: M
authors.lastname: Matsumoto
mesh_terms: D000818:Animals; D001714:Bipolar Disorder / Q000235:genetics*; D054732:Calcium-Calmodulin-Dependent Protein Kinase Type 2 / Q000235:genetics*; D002478:Cells, Cultured; D018891:Dentate Gyrus / Q000254:growth & development* / Q000378:metabolism; D004195:Disease Models, Animal; D006624:Hippocampus / Q000254:growth & development / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D058953:Neural Stem Cells / Q000166:cytology* / Q000378:metabolism; D055495:Neurogenesis / Q000235:genetics* / Q000502:physiology; D009474:Neurons / Q000166:cytology* / Q000378:metabolism; D010641:Phenotype; D012559:Schizophrenia / Q000235:genetics*
chemical_list: D054732:Calcium-Calmodulin-Dependent Protein Kinase Type 2; C517671:Camk2a protein, mouse